Aptevo Therapeutics Inc.
APVO
$4.39
-$0.39-8.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.70M | -24.13M | -23.72M | -24.95M | -27.02M |
| Total Depreciation and Amortization | 307.00K | 352.00K | 397.00K | 436.00K | 495.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 530.00K | 1.07M | 1.50M | 1.81M | 2.00M |
| Change in Net Operating Assets | -842.00K | -1.08M | -1.45M | -1.59M | 1.58M |
| Cash from Operations | -23.71M | -23.79M | -23.28M | -24.30M | -22.95M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 15.60M | 15.60M | 11.93M | 11.36M | 7.87M |
| Repurchase of Common Stock | -1.00K | -1.00K | -3.00K | -3.00K | -2.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -3.00K | -3.00K | -3.00K | -3.00K |
| Cash from Financing | 15.60M | 15.60M | 11.92M | 11.36M | 7.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.11M | -8.19M | -11.36M | -12.94M | -15.08M |